Pfizer Historical PE Ratio image   This PFE PE ratio history page last updated 10/31/2024
Pfizer Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2024
10/29/2024
28.461.064.246.7
Q2 2024
7/30/2024
31.390.602.4013.1
Q1 2024
5/1/2024
27.180.823.288.3
Q4 2023
1/30/2024
27.020.100.4067.5
Q3 2023
10/31/2023
30.56-0.17-0.68NA
Q2 2023
8/1/2023
35.610.672.6813.3
Q1 2023
5/2/2023
39.061.234.927.9
Q4 2022
1/31/2023
44.161.144.569.7
Q3 2022
11/1/2022
48.011.787.126.7
Q2 2022
7/28/2022
50.722.048.166.2
Q1 2022
5/3/2022
49.291.626.487.6
Q4 2021
2/8/2022
51.701.084.3212.0
Q3 2021
11/2/2021
45.451.345.368.5
Q2 2021
7/28/2021
43.451.074.2810.2
Q1 2021
5/4/2021
39.950.933.7210.7
Q4 2020
2/2/2021
34.990.421.6820.8
Q3 2020
10/27/2020
35.510.722.8812.3
Q2 2020
7/28/2020
37.020.783.1211.9
Q1 2020
4/28/2020
35.970.803.2011.2
Q4 2019
1/28/2020
36.190.552.2016.4
Q3 2019
10/29/2019
36.250.753.0012.1
Q2 2019
7/29/2019
39.330.803.2012.3
Q1 2019
4/30/2019
38.530.853.4011.3
Q4 2018
1/29/2019
38.680.642.5615.1
Q3 2018
10/30/2018
40.690.783.1213.0
Q2 2018
7/31/2018
37.880.813.2411.7
Q1 2018
5/1/2018
33.590.773.0810.9
Q4 2017
1/30/2018
35.860.622.4814.5
Q3 2017
10/31/2017
33.260.672.6812.4
Q2 2017
8/1/2017
31.390.672.6811.7
Q1 2017
5/2/2017
31.890.692.7611.6
Q4 2016
1/31/2017
30.100.471.8816.0
Q3 2016
11/1/2016
29.480.612.4412.1
Q2 2016
8/2/2016
34.530.642.5613.5
Q1 2016
5/3/2016
31.970.672.6811.9
Q4 2015
2/2/2016
28.600.532.1213.5
Q3 2015
10/27/2015
33.200.602.4013.8
Q2 2015
7/28/2015
33.540.562.2415.0
Q1 2015
4/28/2015
32.710.512.0416.0
Q4 2014
1/27/2015
30.930.542.1614.3
Q3 2014
10/28/2014
27.600.572.2812.1
Q2 2014
7/29/2014
28.210.582.3212.2
Q1 2014
5/5/2014
28.430.572.2812.5
Q4 2013
1/28/2014
28.860.562.2412.9
Q3 2013
10/29/2013
29.650.582.3212.8
Q2 2013
7/30/2013
28.150.562.2412.6
Q1 2013
4/30/2013
27.580.542.1612.8
Q4 2012
1/29/2013
26.280.471.8814.0
Q3 2012
11/1/2012
23.290.532.1211.0
Q2 2012
7/31/2012
22.810.622.489.2
Q1 2012
4/26/2012
21.880.240.9622.8
Pfizer PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2024
10/29/2024
28.461.062.5811.0
Q2 2024
7/30/2024
31.390.601.3523.3
Q1 2024
5/1/2024
27.180.821.4219.1
Q4 2023
1/30/2024
27.020.101.8314.8
Q3 2023
10/31/2023
30.56-0.172.8710.6
Q2 2023
8/1/2023
35.610.674.827.4
Q1 2023
5/2/2023
39.061.236.196.3
Q4 2022
1/31/2023
44.161.146.586.7
Q3 2022
11/1/2022
48.011.786.527.4
Q2 2022
7/28/2022
50.722.046.088.3
Q1 2022
5/3/2022
49.291.625.119.6
Q4 2021
2/8/2022
51.701.084.4211.7
Q3 2021
11/2/2021
45.451.343.7612.1
Q2 2021
7/28/2021
43.451.073.1413.8
Q1 2021
5/4/2021
39.950.932.8514.0
Q4 2020
2/2/2021
34.990.422.7212.9
Q3 2020
10/27/2020
35.510.722.8512.5
Q2 2020
7/28/2020
37.020.782.8812.9
Q1 2020
4/28/2020
35.970.802.9012.4
Q4 2019
1/28/2020
36.190.552.9512.3
Q3 2019
10/29/2019
36.250.753.0411.9
Q2 2019
7/29/2019
39.330.803.0712.8
Q1 2019
4/30/2019
38.530.853.0812.5
Q4 2018
1/29/2019
38.680.643.0012.9
Q3 2018
10/30/2018
40.690.782.9813.7
Q2 2018
7/31/2018
37.880.812.8713.2
Q1 2018
5/1/2018
33.590.772.7312.3
Q4 2017
1/30/2018
35.860.622.6513.5
Q3 2017
10/31/2017
33.260.672.5013.3
Q2 2017
8/1/2017
31.390.672.4412.9
Q1 2017
5/2/2017
31.890.692.4113.2
Q4 2016
1/31/2017
30.100.472.3912.6
Q3 2016
11/1/2016
29.480.612.4512.0
Q2 2016
8/2/2016
34.530.642.4414.2
Q1 2016
5/3/2016
31.970.672.3613.5
Q4 2015
2/2/2016
28.600.532.2013.0
Q3 2015
10/27/2015
33.200.602.2115.0
Q2 2015
7/28/2015
33.540.562.1815.4
Q1 2015
4/28/2015
32.710.512.2014.9
Q4 2014
1/27/2015
30.930.542.2613.7
Q3 2014
10/28/2014
27.600.572.2812.1
Q2 2014
7/29/2014
28.210.582.2912.3
Q1 2014
5/5/2014
28.430.572.2712.5
Q4 2013
1/28/2014
28.860.562.2412.9
Q3 2013
10/29/2013
29.650.582.1513.8
Q2 2013
7/30/2013
28.150.562.1013.4
Q1 2013
4/30/2013
27.580.542.1612.8
Q4 2012
1/29/2013
26.280.471.8614.1
Q3 2012
11/1/2012
23.290.53NANA
Q2 2012
7/31/2012
22.810.62NANA
Q1 2012
4/26/2012
21.880.24NANA
Quotes delayed 20 minutes

Email EnvelopeFree PFE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Pfizer (PFE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PGEN PE Ratio History
PGNY PE Ratio History
PHAS PE Ratio History
PHAT PE Ratio History
PHIO PE Ratio History
PIII PE Ratio History
PKI PE Ratio History
PLRX PE Ratio History
PLSE PE Ratio History
PLXP PE Ratio History
How should the PFE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Pfizer. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PFE Historical PE Ratio page.

What is the average historical PE for PFE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PFE historical PE ratio using the annualized quarterly earnings method works out to 13.4.

What is the average historical PE for PFE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PFE historical PE ratio using the TTM earnings method works out to 12.7.

What is the average historical PE for PFE based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The PFE historical PE ratio using the annualized median TTM earnings method works out to 2.84.

On this page we presented the Pfizer Historical PE Ratio information for Pfizer' stock. The average PFE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 13.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PFE historical PE based on this TTM earnings result method is 12.7. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PFE historical PE result, against the recent PE: when this page was posted on 10/30/2024, the most recent closing price for PFE had been 28.52, and the most recent quarterly earnings result, annualized, was 4.24. Meanwhile, the most recent TTM earnings summed to 2.58. From these numbers, we calculate the recent PFE PE on 10/30/2024 based on annualized quarterly EPS was 6.7. Based on PFE's history, that recent PE is low relative to the historical average, with the recent PE 50.0% lower than the historical average PE across our data set for Pfizer. Looking at the recent PFE PE on 10/30/2024 based on TTM EPS, we calculate the ratio at 11.1. Based on PFE's history, that recent PE is low relative to the historical average, with the recent PE 12.6% lower than the average PE across our Pfizer data set with TTM EPS used in the calculation at each period.

Another interesting PFE historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for PFE, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for PFE, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.10, 0.60, 0.82, and 1.06. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.60 and 0.82 — which gives us the median of 0.71. Basically the way to think about this 0.71 number is this: for the trailing four earnings reports, 0.71 marks the "middle ground" number where PFE has reported a value higher than 0.71 half the time, and has reported a value lower than 0.71 half the time. Annualizing that median value then gets us to 2.84/share, which we use as the denominator in our next PE calculation. With 28.52 as the numerator (as of 10/30/2024), the calculation is then 28.52 / 2.84 = 10.0 as the PFE PE ratio as of 10/30/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on PFE or any other given stock, valuation analysis for PFE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Pfizer PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PFE. Thanks for visiting, and the next time you need to research PFE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: WIP Historical Stock Prices, Funds Holding DXPE, RMED YTD Return.

 

Pfizer Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.